Exercise therapy in Type 2 diabetes

Acta Diabetologica

Volumn 46, Issue 4, 2009, Pages 263-278

  Praet, Stephan F E ^a   Van Loon, Luc J C ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Complications; Exercise prescription; Pathophysiology; Safety; Treatment adherence; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ANTILIPEMIC AGENT; GLUCOSE;

ANTIHYPERTENSIVE ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; ENERGY EXPENDITURE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INTERVENTION STUDY; KINESIOTHERAPY; LIPID METABOLISM; LIPID STORAGE; LONG TERM CARE; MEDICAL LITERATURE; METABOLIC DISORDER; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; HUMANS; TREATMENT OUTCOME;

EID: 70449526557     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0129-0     Document Type: Review

References (273)

1. Aretaeus (1972) Of Aretaeus, the Cappadocian. Causes and symptoms of chronic disease, Book I, Chapter II 'ON DIABETES'. In: Francis Adams LLD (ed) The extant works of Aretaeus, The Cappadocian. Digital Hippocrates Collection. A collection of ancient medical texts. Boston Milford House Inc., Milford, p 91 (Republication of the 1856 edition
2. E Lancereaux 1880 Le diabete maigre: ses symptomes, son evolution, son prognostie et son traitement Un. Med Paris 20 205 211
3. G Pincus EP Joslin P White 1934 Age-incidence relations in diabetes mellitus Am J Med Sci 188 116 121
4. P Zimmet 2000 Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 247 301 310 10762445
5. MM Engelgau LS Geiss JB Saaddine, et al.. 2004 The evolving diabetes burden in the United States Ann Intern Med 140 945 950 15172919
6. JC Seidell 2000 Obesity, insulin resistance and diabetes-a worldwide epidemic Br J Nutr 83 Suppl 1 S5 S8 10889785
7. AH Mokdad BA Bowman ES Ford F Vinicor JS Marks JP Koplan 2001 The continuing epidemics of obesity and diabetes in the United States JAMA 286 1195 1200 11559264
8. R Sladek G Rocheleau J Rung, et al.. 2007 A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 881 885 17293876
9. R Saxena BF Voight V Lyssenko, et al.. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 17463246
10. I Prokopenko C Langenberg JC Florez, et al.. 2009 Variants in MTNR1B influence fasting glucose levels Nat Genet 41 77 81 19060907
11. S Cauchi D Meyre E Durand, et al.. 2008 Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value PLoS ONE 3 e2031 18461161
12. PW Sullivan EH Morrato V Ghushchyan HR Wyatt JO Hill 2005 Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000-2002 Diabetes Care 28 1599 1603 15983307
13. M van Hoek A Dehghan JC Witteman, et al.. 2008 Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study Diabetes 57 3122 3128 18694974
14. V Lyssenko L Groop 2009 Genome-wide association study for type 2 diabetes: clinical applications Curr Opin Lipidol 20 87 91 19276887
15. IDF (2008) Diabetes: a global threat. Diabetes Atlas, 3rd edn. IDF, Brussels, pp 1-15. http://www.eatlas.idf.org/index1397.html
16. World Health Organization Expert Committee (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
17. WHO/IDF (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. World Health Organisation, Geneva
18. B Costa J Vizcaino JL Pinol JJ Cabre CM Fuentes 2007 Relevance of casual undetected hyperglycemia among high-risk individuals for developing diabetes Diabetes Res Clin Pract 78 289 292 17448563
19. RJ Manders SF Praet MH Vikstrom WH Saris LJ van Loon 2009 Protein hydrolysate co-ingestion does not modulate 24 h glycemic control in long-standing type 2 diabetes patients Eur J Clin Nutr 63 121 126 17717533
20. SF Praet RJ Manders RC Meex, et al.. 2006 Glycaemic instability is an underestimated problem in Type II diabetes Clin Sci (Lond) 111 119 126
21. A Ceriello 2005 Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54 1 7 15616004
22. AD Baron 2001 Impaired glucose tolerance as a disease Am J Cardiol 88 16H 19H 11576521
23. M Stumvoll BJ Goldstein TW van Haeften 2005 Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 1333 1346 15823385
24. JR Perry MI Mc Carthy AT Hattersley E Zeggini MN Weedon TM Frayling 2009 Interrogating Type 2 diabetes genome-wide association data using a biological pathway-based approach Diabetes 58 1463 1467 19252133
25. G Perseghin S Ghosh K Gerow GI Shulman 1997 Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study Diabetes 46 1001 1009 9166672
26. R Taylor 2008 Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause Diabetologia 51 1781 1789 18726585
27. RP Robertson J Harmon PO Tran Y Tanaka H Takahashi 2003 Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection Diabetes 52 581 587 12606496
28. M Dubois J Kerr-Conte V Gmyr, et al.. 2004 Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration Diabetologia 47 463 469 14968298
29. RL Hull GT Westermark P Westermark SE Kahn 2004 Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes J Clin Endocrinol Metab 89 3629 3643 15292279
30. SE Kahn SM Haffner MA Heise, et al.. 2006 Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2427 2443 17145742
31. JJ Holst 2006 Glucagon-like peptide-1: from extract to agent. The Claude Bernard lecture, 2005 Diabetologia 49 253 260 16416146
32. DJ Drucker MA Nauck 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 1696 1705 17098089
33. DA D'Alessio AM Denney LM Hermiller, et al.. 2009 Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes J Clin Endocrinol Metab 94 81 88 18957505
34. J Rosenstock JE Foley M Rendell, et al.. 2008 Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance Diabetes Care 31 30 35 17947341
35. B Ahren A Schweizer S Dejager, et al.. 2009 Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with Type 2 diabetes J Clin Endocrinol Metab 94 1236 1243 19174497
36. E Ferrannini V Fonseca B Zinman, et al.. 2009 Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy Diabetes Obes Metab 11 157 166 19125777
37. B Goke K Hershon D Kerr, et al.. 2008 Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naive patients with type 2 diabetes: comparison with metformin Horm Metab Res 40 892 895 18726829
38. TJ Moretto DR Milton TD Ridge, et al.. 2008 Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study Clin Ther 30 1448 1460 18803987
39. K Hermansen M Kipnes E Luo D Fanurik H Khatami P Stein 2007 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin Diabetes Obes Metab 9 733 745 17593236
40. DJ Jenkins CW Kendall LS Augustin V Vuksan 2002 High-complex carbohydrate or lente carbohydrate foods? Am J Med 113 Suppl 9B 30S 37S 12566136
41. RJ Manders SF Praet RC Meex, et al.. 2006 Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients Diabetes Care 29 2721 2722 17130211
42. RJ Manders R Koopman WE Sluijsmans, et al.. 2006 Co-ingestion of a protein hydrolysate with or without additional leucine effectively reduces postprandial blood glucose excursions in Type 2 diabetic men J Nutr 136 1294 1299 16614419
43. LJ van Loon M Kruijshoop PP Menheere AJ Wagenmakers WH Saris HA Keizer 2003 Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes Diabetes Care 26 625 630 12610012
44. AH Frid M Nilsson JJ Holst IM Bjorck 2005 Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects Am J Clin Nutr 82 69 75 16002802
45. DM Nathan JB Buse MB Davidson, et al.. 2006 Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 29 1963 1972 16873813
46. SE Kahn RL Hull KM Utzschneider 2006 Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 840 846 17167471
47. G Boden X Chen 1995 Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes J Clin Invest 96 1261 1268 7657800
48. G Boden 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 3 10 8971073
49. M Kabir KJ Catalano S Ananthnarayan, et al.. 2005 Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance Am J Physiol Endocrinol Metab 288 E454 E461 15522994
50. KF Petersen S Dufour D Befroy M Lehrke RE Hendler GI Shulman 2005 Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 603 608 15734833
51. RA Mooney J Senn S Cameron, et al.. 2001 Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance J Biol Chem 276 25889 25893 11342531
52. M Perreault A Marette 2001 Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle Nat Med 7 1138 1143 11590438
53. H Xu GT Barnes Q Yang, et al.. 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 1821 1830 14679177
54. TE Graham Q Yang M Bluher, et al.. 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects N Engl J Med 354 2552 2563 16775236
55. Q Yang TE Graham N Mody, et al.. 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 356 362 16034410
56. P Balagopal TE Graham BB Kahn A Altomare V Funanage D George 2007 Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation J Clin Endocrinol Metab 92 1971 1974 17341558
57. DG Haider K Schindler F Mittermayer, et al.. 2007 Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients Clin Pharmacol Ther 81 580 585 17235334
58. DG Haider K Schindler G Prager, et al.. 2007 Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects J Clin Endocrinol Metab 92 1168 1171 17164313
59. SM Furler SK Gan AM Poynten DJ Chisholm LV Campbell AD Kriketos 2006 Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability Obesity (Silver Spring) 14 228 234
60. T Kadowaki T Yamauchi N Kubota K Hara K Ueki K Tobe 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J Clin Invest 116 1784 1792 16823476
61. BK Pedersen 2006 The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control Essays Biochem 42 105 117 17144883
62. LJ van Loon BH Goodpaster 2006 Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state Pflugers Arch 451 606 616 16155759
63. DE Larson-Meyer LK Heilbronn LM Redman, et al.. 2006 Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects Diabetes Care 29 1337 1344 16732018
64. CR Bruce AD Kriketos GJ Cooney JA Hawley 2004 Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes Diabetologia 47 23 30 14673522
65. LJ van Loon RJ Manders R Koopman, et al.. 2005 Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients Diabetologia 48 2097 2107 16096823 (Pubitemid 41416922)
66. LJ van Loon M Thomason-Hughes D Constantin-Teodosiu, et al.. 2005 Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans Am J Physiol Endocrinol Metab 289 E482 E493 15886227
67. LJ van Loon R Koopman R Manders W van der Weegen GP van Kranenburg HA Keizer 2004 Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes Am J Physiol Endocrinol Metab 287 E558 E565 15165998
68. H Boon EE Blaak WH Saris HA Keizer AJ Wagenmakers LJ van Loon 2007 Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery Diabetologia 50 103 112 17131144
69. AP Russell G Gastaldi E Bobbioni-Harsch, et al.. 2003 Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 551 104 106 12965212
70. KF Petersen GI Shulman 2006 Etiology of insulin resistance Am J Med 119 S10 S16 16563942
71. GI Shulman 2000 Cellular mechanisms of insulin resistance J Clin Invest 106 171 176 10903330
72. L Ryysy AM Hakkinen T Goto, et al.. 2000 Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients Diabetes 49 749 758 10905483
73. D Cai M Yuan DF Frantz, et al.. 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 183 190 15685173
74. VT Samuel ZX Liu X Qu, et al.. 2004 Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J Biol Chem 279 32345 32353 15166226
75. VT Samuel ZX Liu A Wang, et al.. 2007 Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease J Clin Invest 117 739 745 17318260
76. A Goldin JA Beckman AM Schmidt MA Creager 2006 Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 597 605 16894049
77. CG Schalkwijk M Lieuw-a-Fa VW van Hinsbergh CD Stehouwer 2002 Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy Semin Vasc Med 2 191 197 16222610
78. M Brownlee 2001 Biochemistry and molecular cell biology of diabetic complications Nature 414 813 820 11742414
79. M Hogan A Cerami R Bucala 1992 Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 90 1110 1115
80. T Nishikawa D Edelstein M Brownlee 2000 The missing link: a single unifying mechanism for diabetic complications Kidney Int Suppl 77 S26 S30 10997687
81. AM Vincent L Perrone KA Sullivan, et al.. 2007 Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress Endocrinology 148 548 558 17095586
82. JL Evans ID Goldfine BA Maddux GM Grodsky 2002 Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr Rev 23 599 622 12372842
83. R Wada S Yagihashi 2005 Role of advanced glycation end products and their receptors in development of diabetic neuropathy Ann N Y Acad Sci 1043 598 604 16037282
84. P Rosen PP Nawroth G King W Moller HJ Tritschler L Packer 2001 The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society Diabetes Metab Res Rev 17 189 212 11424232
85. R Da Ros R Assaloni A Ceriello 2005 Molecular targets of diabetic vascular complications and potential new drugs Curr Drug Targets 6 503 509 16026269
86. A Stitt TA Gardiner NL Alderson, et al.. 2002 The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2826 2832 12196477
87. LL Ji 2002 Exercise-induced modulation of antioxidant defense Ann N Y Acad Sci 959 82 92 11976188
88. GR Stoppa M Cesquini EA Roman SH Ogo MA Torsoni 2006 Aminoguanidine prevented impairment of blood antioxidant system in insulin-dependent diabetic rats Life Sci 78 1352 1361 16229859
89. V Saengsirisuwan FR Perez JA Sloniger T Maier EJ Henriksen 2004 Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats Am J Physiol Endocrinol Metab 287 E529 E536 15068957
90. S Balducci G Iacobellis L Parisi, et al.. 2006 Exercise training can modify the natural history of diabetic peripheral neuropathy J Diabetes Complications 20 216 223 16798472
91. D Ziegler A Ametov A Barinov, et al.. 2006 Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Diabetes Care 29 2365 2370 17065669
92. EJ Henriksen 2006 Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes Free Radic Biol Med 40 3 12 16337874
93. JG Regensteiner J Sippel ET McFarling EE Wolfel WR Hiatt 1995 Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise Med Sci Sports Exerc 27 875 881 7658949
94. JG Regensteiner TA Bauer JE Reusch, et al.. 1998 Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus J Appl Physiol 85 310 317 9655791
95. RO Estacio EE Wolfel JG Regensteiner, et al.. 1996 Effect of risk factors on exercise capacity in NIDDM Diabetes 45 79 85 8522064
96. BB Lowell GI Shulman 2005 Mitochondrial dysfunction and type 2 diabetes Science 307 384 387 15662004
97. HM De Feyter NM van den Broek SF Praet K Nicolay LJ van Loon JJ Prompers 2008 Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction Eur J Endocrinol 158 643 653 18426822
98. MI Trenell KG Hollingsworth EL Lim R Taylor 2008 Increased daily walking improves lipid oxidation without changes in mitochondrial function in Type 2 diabetes Diabetes Care 31 1644 1649 18487474
99. KF Petersen S Dufour D Befroy R Garcia GI Shulman 2004 Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N Engl J Med 350 664 671 14960743
100. KF Petersen D Befroy S Dufour, et al.. 2003 Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 300 1140 1142 12750520
101. DE Kelley J He EV Menshikova VB Ritov 2002 Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2944 2950 12351431
102. Short KR, Nair KS, Stump CS (2004) Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:2419-2421; author reply 2419-2421
103. JA Simoneau DE Kelley 1997 Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM J Appl Physiol 83 166 171 9216960
104. R Rabol R Boushel F Dela 2006 Mitochondrial oxidative function and type 2 diabetes Appl Physiol Nutr Metab 31 675 683 17213881
105. J Szendroedi AI Schmid M Chmelik, et al.. 2007 Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes PLoS Med 4 e154 17472434
106. JA Hawley SJ Lessard 2007 Mitochondrial function: use it or lose it Diabetologia 50 699 702 17279353
107. VB Schrauwen-Hinderling ME Kooi MK Hesselink, et al.. 2007 Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects Diabetologia 50 113 120 17093944
108. B Sirikul BA Gower GR Hunter DE Larson-Meyer BR Newcomer 2006 Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle Am J Physiol Endocrinol Metab 291 E724 E728 16705059
109. M Mogensen K Sahlin M Fernstrom, et al.. 2007 Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 1592 1599 17351150
110. R Boushel E Gnaiger P Schjerling M Skovbro R Kraunsoe F Dela 2007 Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle Diabetologia 50 790 796 17334651
111. C Brons CB Jensen H Storgaard, et al.. 2008 Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight J Clin Endocrinol Metab 93 3885 3892 18628517
112. MW Schwartz D Porte Jr 2005 Diabetes, obesity, and the brain Science 307 375 379 15662002
113. D Porte Jr DG Baskin MW Schwartz 2005 Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C elegans to humans. Diabetes 54 1264 1276
114. L Landsberg 2001 Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why) J Hypertens 19 523 528 11327624
115. MS Muntzel EA Anderson AK Johnson AL Mark 1995 Mechanisms of insulin action on sympathetic nerve activity Clin Exp Hypertens 17 39 50 7735284
116. JC Dunbar H Lu 1999 Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products Brain Res Bull 50 215 221 10566984
117. N Tentolouris S Liatis N Katsilambros 2006 Sympathetic system activity in obesity and metabolic syndrome Ann N Y Acad Sci 1083 129 152 17148737
118. S Frontoni D Bracaglia A Baroni, et al.. 2003 Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients Hypertension 41 1223 1227 12743012
119. AI Vinik RE Maser BD Mitchell R Freeman 2003 Diabetic autonomic neuropathy Diabetes Care 26 1553 1579 12716821 (Pubitemid 36934465)
120. D Ziegler C Zentai S Perz, et al.. 2006 Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population Exp Clin Endocrinol Diabetes 114 153 159 16710813
121. RW Nesto 2004 Correlation between cardiovascular disease and diabetes mellitus: current concepts Am J Med 116 Suppl 5A 11S 22S 15019859
122. AM Spijkerman RM Henry JM Dekker, et al.. 2004 Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study J Intern Med 256 429 436 15485479
123. J Gerritsen JM Dekker BJ TenVoorde, et al.. 2001 Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study Diabetes Care 24 1793 1798 11574444
124. HM Colhoun DJ Betteridge PN Durrington, et al.. 2004 Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 685 696 15325833
125. R Scott R O'Brien G Fulcher, et al.. 2009 Effects of fenofibrate treatment on cardiovascular disease risk in 9, 795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetes Care 32 493 498 18984774
126. A Patel S MacMahon J Chalmers, et al.. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 829 840 17765963
127. Turner R, et al. (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J 317:703-713 (Pubitemid 28414300)
128. JS Skyler R Bergenstal RO Bonow, et al.. 2009 Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care 32 187 192 19092168
129. IM Stratton CA Cull AI Adler DR Matthews HA Neil RR Holman 2006 Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia 49 1761 1769 16736131
130. UK Prospective Diabetes Study Group U 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853
131. Y Ohkubo H Kishikawa E Araki, et al.. 1995 Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res Clin Pract 28 103 117 7587918
132. A Patel S MacMahon J Chalmers, et al.. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 18539916
133. SE Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2457 2471 17517853 (Pubitemid 46919772)
134. HC Gerstein ME Miller RP Byington, et al.. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 18539917
135. W Duckworth C Abraira T Moritz, et al.. 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139 19092145
136. X Pi-Sunyer G Blackburn FL Brancati, et al.. 2007 Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial Diabetes Care 30 1374 1383 17363746
137. DW Dunstan TA Mori IB Puddey, et al.. 1997 The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM A randomized controlled study. Diabetes Care 20 913 921
138. J Lindstrom P Ilanne-Parikka M Peltonen, et al.. 2006 Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Lancet 368 1673 1679 17098085 (Pubitemid 46048554)
139. E Vanninen M Uusitupa O Siitonen J Laitinen E Lansimies 1992 Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention Diabetologia 35 340 346 1516762
140. PA Torjesen KI Birkeland SA Anderssen I Hjermann I Holme P Urdal 1997 Lifestyle changes may reverse development of the insulin resistance syndrome The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 20 26 31
141. H Kishimoto A Taniguchi M Fukushima, et al.. 2002 Effect of short-term low-intensity exercise on insulin sensitivity, insulin secretion, and glucose and lipid metabolism in non-obese Japanese type 2 diabetic patients Horm Metab Res 34 27 31 11832998
142. S Balducci F Leonetti U Di Mario F Fallucca 2004 Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients? Diabetes Care 27 841 842 14988317
143. BK Pedersen MA Febbraio 2008 Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 88 1379 1406 18923185
144. EL Madsen A Rissanen JM Bruun, et al.. 2008 Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study Eur J Endocrinol 158 179 187 18230824
145. LU Monzillo O Hamdy ES Horton, et al.. 2003 Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance Obes Res 11 1048 1054 12972674 (Pubitemid 41151581)
146. HM De Feyter SF Praet NM van den Broek, et al.. 2007 Exercise training improves glycemic control in long-standing, insulin-treated type 2 diabetes patients Diabetes Care 30 2511 2513 17626892
147. CP Lambert NR Wright BN Finck DT Villareal 2008 Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons J Appl Physiol 105 473 478 18535122
148. V Castellano DI Patel LJ White 2008 Cytokine responses to acute and chronic exercise in multiple sclerosis J Appl Physiol 104 1697 1702 18388249
149. LK Stewart MG Flynn WW Campbell, et al.. 2007 The influence of exercise training on inflammatory cytokines and C-reactive protein Med Sci Sports Exerc 39 1714 1719 17909397
150. E Goldhammer A Tanchilevitch I Maor Y Beniamini U Rosenschein M Sagiv 2005 Exercise training modulates cytokines activity in coronary heart disease patients Int J Cardiol 100 93 99 15820291
151. F Mattusch B Dufaux O Heine I Mertens R Rost 2000 Reduction of the plasma concentration of C-reactive protein following nine months of endurance training Int J Sports Med 21 21 24 10683094
152. R Starkie SR Ostrowski S Jauffred M Febbraio BK Pedersen 2003 Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans FASEB J 17 884 886 12626436
153. Thomas DE, Elliott EJ, Naughton GA (2006) Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 3:CD002968
154. NJ Snowling WG Hopkins 2006 Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis Diabetes Care 29 2518 2527 17065697
155. M Halle A Berg U Garwers, et al.. 1999 Influence of 4 weeks' intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes Metabolism 48 641 644 10337867
156. A Krook I Holm S Pettersson H Wallberg-Henriksson 2003 Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus Clin Physiol Funct Imaging 23 21 30 12558610
157. RJ Sigal GP Kenny NG Boule, et al.. 2007 Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial Ann Intern Med 147 357 369 17876019
158. WC Miller DM Koceja EJ Hamilton 1997 A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention Int J Obes Relat Metab Disord 21 941 947 9347414
159. KR Westerterp 1999 Obesity and physical activity Int J Obes Relat Metab Disord 23 Suppl 1 59 64 10193864
160. D Hansen P Dendale J Berger LJ van Loon R Meeusen 2007 The effects of exercise training on fat-mass loss in obese patients during energy intake restriction Sports Med 37 31 46 17190534
161. V Stich M Berlan 2004 Physiological regulation of NEFA availability: lipolysis pathway Proc Nutr Soc 63 369 374 15294057
162. S Paglialunga K Cianflone 2007 Regulation of postprandial lipemia: an update on current trends Appl Physiol Nutr Metab 32 61 75 17332785
163. M Stolinski S Alam NC Jackson, et al.. 2008 Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus Metabolism 57 1608 1614 18940401
164. G Perseghin G Lattuada F De Cobelli, et al.. 2007 Habitual physical activity is associated with intrahepatic fat content in humans Diabetes Care 30 683 688 17327341
165. F Shojaee-Moradie KC Baynes C Pentecost, et al.. 2007 Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism Diabetologia 50 404 413 17149589
166. Y Tamura Y Tanaka F Sato, et al.. 2005 Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2
167. S Pastromas AB Terzi D Tousoulis S Koulouris 2008 Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus Int J Cardiol 7 3 12
168. American Diabetes Association 2009 Standards of medical care in diabetes-2009 Diabetes Care 32 Suppl 1 S13 S61
169. RJ Sigal GP Kenny DH Wasserman C Castaneda-Sceppa RD White 2006 Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association Diabetes Care 29 1433 1438 16732040
170. American Diabetes Association 2009 Standards of medical care in diabetes-2009 Diabetes Care 32 Suppl 1 S13 S64
171. JT Devlin M Hirshman ED Horton ES Horton 1987 Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise Diabetes 36 434 439 3102297
172. LM Fenicchia JA Kanaley JL Azevedo Jr, et al.. 2004 Influence of resistance exercise training on glucose control in women with type 2 diabetes Metabolism 53 284 289 15015138
173. R Koopman RJ Manders AH Zorenc, et al.. 2005 A single session of resistance exercise enhances insulin sensitivity for at least 24 h in healthy men Eur J Appl Physiol 94 180 187 15761746
174. PM Garcia-Roves DH Han Z Song TE Jones KA Hucker JO Holloszy 2003 Prevention of glycogen supercompensation prolongs the increase in muscle GLUT4 after exercise Am J Physiol Endocrinol Metab 285 E729 E736 12799316
175. A Sriwijitkamol DK Coletta E Wajcberg, et al.. 2007 Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study Diabetes 56 836 848 17327455
176. RR Pencek PT Fueger RC Camacho DH Wasserman 2005 Mobilization of glucose from the liver during exercise and replenishment afterward Can J Appl Physiol 30 292 303 16129894
177. TB Price DL Rothman RG Shulman 1999 NMR of glycogen in exercise Proc Nutr Soc 58 851 859 10817152
178. F Dela JJ Larsen KJ Mikines T Ploug LN Petersen H Galbo 1995 Insulin-stimulated muscle glucose clearance in patients with NIDDM Effects of one-legged physical training. Diabetes 44 1010 1020
179. VA Bisquolo CG Cardoso Jr KC Ortega, et al.. 2005 Previous exercise attenuates muscle sympathetic activity and increases blood flow during acute euglycemic hyperinsulinemia J Appl Physiol 98 866 871 15542577
180. K Mandroukas M Krotkiewski G Holm, et al.. 1986 Muscle adaptations and glucose control after physical training in insulin-dependent diabetes mellitus Clin Physiol 6 39 52 3943285
181. J Henriksson 1992 Effects of physical training on the metabolism of skeletal muscle Diabetes Care 15 1701 1711 1468304
182. E Cauza U Hanusch-Enserer B Strasser K Kostner A Dunky P Haber 2005 Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system Eur J Clin Invest 35 745 751 16313250
183. H Wagner M Degerblad A Thorell, et al.. 2006 Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes Diabetes Care 29 1471 1477 16801564
184. SH Schneider LF Amorosa AK Khachadurian NB Ruderman 1984 Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes Diabetologia 26 355 360 6376244
185. K Howorka J Pumprla P Haber J Koller-Strametz J Mondrzyk A Schabmann 1997 Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy Cardiovasc Res 34 206 214 9217892 (Pubitemid 27261931)
186. Farrell PA (2001) Protein metabolism and age: influence of insulin and resistance exercise. Int J Sport Nutr Exerc Metab 11(Suppl):S150-S163
187. R Koopman AH Zorenc RJ Gransier D Cameron-Smith LJ van Loon 2006 Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers Am J Physiol Endocrinol Metab 290 E1245 E1252 16434552
188. DW Dunstan RM Daly N Owen, et al.. 2002 High-intensity resistance training improves glycemic control in older patients with type 2 diabetes Diabetes Care 25 1729 1736 12351469
189. C Castaneda JE Layne L Munoz-Orians, et al.. 2002 A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes Diabetes Care 25 2335 2341 12453982
190. F Dela KJ Mikines M von Linstow NH Secher H Galbo 1992 Effect of training on insulin-mediated glucose uptake in human muscle Am J Physiol 263 E1134 E1143 1476187
191. SE Kahn VG Larson JC Beard, et al.. 1990 Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging Am J Physiol 258 E937 E943 2193534
192. F Dela T Ploug A Handberg, et al.. 1994 Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM Diabetes 43 862 865 8013748
193. G Perseghin TB Price KF Petersen, et al.. 1996 Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects N Engl J Med 335 1357 1362 8857019
194. MA Rogers C Yamamoto JM Hagberg WH Martin III AA Ehsani JO Holloszy 1988 Effect of 6 d of exercise training on responses to maximal and sub-maximal exercise in middle-aged men Med Sci Sports Exerc 20 260 264 3386505
195. A Maiorana G O'Driscoll R Taylor D Green 2003 Exercise and the nitric oxide vasodilator system Sports Med 33 1013 1035 14599231
196. KR Segal A Edano A Abalos, et al.. 1991 Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men J Appl Physiol 71 2402 2411 1778939
197. CR Bruce JA Hawley 2004 Improvements in insulin resistance with aerobic exercise training: a lipocentric approach Med Sci Sports Exerc 36 1196 1201 15235325
198. MK Holten M Zacho M Gaster C Juel JF Wojtaszewski F Dela 2004 Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes Diabetes 53 294 305 14747278
199. R Koopman RJ Manders RA Jonkers GB Hul H Kuipers LJ van Loon 2006 Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males Eur J Appl Physiol 96 525 534 16369816
200. JJ Larsen F Dela S Madsbad H Galbo 1999 The effect of intense exercise on postprandial glucose homeostasis in type II diabetic patients Diabetologia 42 1282 1292 10550411 (Pubitemid 29500964)
201. JJ Larsen F Dela M Kjaer H Galbo 1997 The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients Diabetologia 40 447 453 9112022
202. C Di Loreto C Fanelli P Lucidi, et al.. 2005 Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes Diabetes Care 28 1295 1302 15920042
203. G O'Donovan EM Kearney AM Nevill K Woolf-May SR Bird 2005 The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance Eur J Appl Physiol 95 522 528 16151830
204. B Detournay D Raccah M Cadilhac E Eschwege 2005 Epidemiology and costs of diabetes treated with insulin in France Diabetes Metab 31 3 18 16142041
205. ZY Fang J Sharman JB Prins TH Marwick 2005 Determinants of exercise capacity in patients with type 2 diabetes Diabetes Care 28 1643 1648 15983314
206. RO Estacio JG Regensteiner EE Wolfel B Jeffers M Dickenson RW Schrier 1998 The association between diabetic complications and exercise capacity in NIDDM patients Diabetes Care 21 291 295 9539998
207. Petrofsky JS, Stewart B, Patterson C, Cole M, Al Malty A, Lee S (2005) Cardiovascular responses and endurance during isometric exercise in patients with Type 2 diabetes compared to control subjects. Med Sci Monit 11:CR470-CR477
208. S Volpato C Blaum H Resnick L Ferrucci LP Fried JM Guralnik 2002 Comorbidities and impairments explaining the association between diabetes and lower extremity disability: the Women's Health and Aging Study Diabetes Care 25 678 683 11919124
209. AA Sayer EM Dennison HE Syddall HJ Gilbody DI Phillips C Cooper 2005 Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 28 2541 2542 16186295
210. H Andersen S Nielsen CE Mogensen J Jakobsen 2004 Muscle strength in type 2 diabetes Diabetes 53 1543 1548 15161759
211. C Castaneda I Janssen 2005 Ethnic comparisons of sarcopenia and obesity in diabetes Ethn Dis 15 664 670 16259491
212. K Meyer M Lehmann G Sunder J Keul H Weidemann 1990 Interval versus continuous exercise training after coronary bypass surgery: a comparison of training-induced acute reactions with respect to the effectiveness of the exercise methods Clin Cardiol 13 851 861 2282729
213. K Meyer L Samek M Schwaibold, et al.. 1997 Interval training in patients with severe chronic heart failure: analysis and recommendations for exercise procedures Med Sci Sports Exerc 29 306 312 9139168 (Pubitemid 27123703)
214. A Festa K Williams R D'Agostino Jr LE Wagenknecht SM Haffner 2006 The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study Diabetes 55 1114 1120 16567536
215. RC Camacho RR Pencek DB Lacy FD James DH Wasserman 2004 Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin Diabetes 53 285 293 14747277
216. RJ Sigal C Purdon SJ Fisher JB Halter M Vranic EB Marliss 1994 Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects J Clin Endocrinol Metab 79 1049 1057 7962273
217. C Purdon M Brousson SL Nyveen, et al.. 1993 The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects J Clin Endocrinol Metab 76 566 573 8445012
218. JJ Larsen F Dela S Madsbad J Vibe-Petersen H Galbo 1999 Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients Diabetes Care 22 1647 1654 10526729 (Pubitemid 29458387)
219. MC Riddle PA McDaniel LA Tive 1997 Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM Diabetes Care 20 992 994 9167112
220. EA Gulve 2008 Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy Phys Ther 88 1297 1321 18801852
221. P Galassetti D Tate RA Neill A Richardson SY Leu SN Davis 2006 Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes Am J Physiol Endocrinol Metab 290 E1109 E1117 16403779
222. SN Davis S Mann P Galassetti, et al.. 2000 Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans Diabetes 49 1897 1903 11078457
223. SN Davis S Mann VJ Briscoe AC Ertl DB Tate 2009 Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes Diabetes 58 701 709 19073776
224. A Ceriello 2009 Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? Diabetes Care 32 521 522 19246590
225. CT Kodl ER Seaquist 2008 Cognitive dysfunction and diabetes mellitus Endocr Rev 29 494 511 18436709
226. AM Wessels P Scheltens F Barkhof RJ Heine 2008 Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes Eur J Pharmacol 585 88 96 18396273
227. SF Praet RA Jonkers G Schep, et al.. 2008 Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training Eur J Endocrinol 158 163 172 18230822
228. A Must J Spadano EH Coakley AE Field G Colditz WH Dietz 1999 The disease burden associated with overweight and obesity JAMA 282 1523 1529 10546691
229. T Sturmer H Brenner RE Brenner KP Gunther 2001 Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis The Ulm osteoarthritis study. Scand J Rheumatol 30 169 171
230. SF Praet ES van Rooij A Wijtvliet, et al.. 2008 Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial Diabetologia 51 736 746 18297259
231. SF Praet JW Louwerens 2003 The influence of shoe design on plantar pressures in neuropathic feet Diabetes Care 26 441 445 12547877
232. JE Perry JS Ulbrecht JA Derr PR Cavanagh 1995 The use of running shoes to reduce plantar pressures in patients who have diabetes J Bone Joint Surg Am 77 1819 1828 8550649
233. T Kastenbauer G Sokol M Auinger K Irsigler 1998 Running shoes for relief of plantar pressure in diabetic patients Diabet Med 15 518 522 9632129
234. RV Kanade RW van Deursen K Harding P Price 2006 Walking performance in people with diabetic neuropathy: benefits and threats Diabetologia 49 1747 1754 16758177
235. DW Dunstan E Vulikh N Owen D Jolley J Shaw P Zimmet 2006 Community center-based resistance training for the maintenance of glycemic control in adults with type 2 diabetes Diabetes Care 29 2586 2591 17130189
236. DW Dunstan RM Daly N Owen, et al.. 2005 Home-based resistance training is not sufficient to maintain improved glycemic control following supervised training in older individuals with type 2 diabetes Diabetes Care 28 3 9 15616225
237. SH Schneider AK Khachadurian LF Amorosa L Clemow NB Ruderman 1992 Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus Diabetes Care 15 1800 1810 1468318
238. A Kirk N Mutrie P MacIntyre M Fisher 2004 Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes Diabetologia 47 821 832 15138687
239. DS West V DiLillo Z Bursac SA Gore PG Greene 2007 Motivational interviewing improves weight loss in women with type 2 diabetes Diabetes Care 30 1081 1087 17337504
240. C Tudor-Locke RC Bell AM Myers, et al.. 2004 Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes Int J Obes Relat Metab Disord 28 113 119 14569279
241. A Kirk P De Feo 2007 Strategies to enhance compliance to physical activity for patients with insulin resistance Appl Physiol Nutr Metab 32 549 556 17510696
242. EM Van Sluijs MN Van Poppel JW Twisk J Brug W Van Mechelen 2005 The positive effect on determinants of physical activity of a tailored, general practice-based physical activity intervention Health Educ Res 20 345 356 15479705 (Pubitemid 40732820)
243. N Thomas E Alder GP Leese 2004 Barriers to physical activity in patients with diabetes Postgrad Med J 80 287 291 15138320
244. EM van Sluijs MN van Poppel JW Twisk W van Mechelen 2006 Physical activity measurements affected participants' behavior in a randomized controlled trial J Clin Epidemiol 59 404 411 16549263
245. A Fowler-Brown M Pignone M Pletcher JA Tice SF Sutton KN Lohr 2004 Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force Ann Intern Med 140 W9 W24 15069009
246. ZY Fang R Schull-Meade R Leano PM Mottram JB Prins TH Marwick 2005 Screening for heart disease in diabetic subjects Am Heart J 149 349 354 15846276 (Pubitemid 40348547)
247. FJ Wackers LH Young SE Inzucchi, et al.. 2004 Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study Diabetes Care 27 1954 1961 15277423
248. PA McAuley JN Myers JP Abella SY Tan VF Froelicher 2007 Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes Diabetes Care 30 1539 1543 17351282
249. E Faglia F Favales P Calia, et al.. 2002 Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD) Diabetes Care 25 2032 2036 12401752
250. P Valensi J Paries V Brulport-Cerisier, et al.. 2005 Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study Diabetes Care 28 2722 2727 16249546
251. RJ Stevens V Kothari AI Adler IM Stratton 2001 The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 101 671 679
252. RW Nesto RT Phillips KG Kett, et al.. 1988 Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy Ann Intern Med 108 170 175 3341650
253. RW Nesto 1999 Screening for asymptomatic coronary artery disease in diabetes Diabetes Care 22 1393 1395 10480498
254. E Cosson F Paycha J Paries, et al.. 2004 Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med 21 342 348 15049936
255. JJ Bax RO Bonow D Tschope SE Inzucchi E Barrett 2006 The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes J Am Coll Cardiol 48 754 760 16904545
256. A Schmermund S Mohlenkamp S Berenbein, et al.. 2006 Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography Atherosclerosis 185 177 182 16005882
257. S Bacci M Villella A Villella, et al.. 2002 Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test Eur J Endocrinol 147 649 654 12444897
258. A Elhendy DW Mahoney BK Khandheria K Burger PA Pellikka 2003 Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia J Am Coll Cardiol 42 823 830 12957427
259. SF Praet LJ van Loon 2007 Optimizing the therapeutic benefits of exercise in type 2 diabetes J Appl Physiol 103 1113 1120 17656625
260. UN Toft LH Kristoffersen M Aadahl L von Huth Smith C Pisinger T Jorgensen 2007 Diet and exercise intervention in a general population-mediators of participation and adherence: the Inter99 study Eur J Public Health 17 455 463 17170019
261. HO Chambliss 2005 Exercise duration and intensity in a weight-loss program Clin J Sport Med 15 113 115 15782062
262. I Bautista-Castano J Molina-Cabrillana JA Montoya-Alonso L Serra-Majem 2004 Variables predictive of adherence to diet and physical activity recommendations in the treatment of obesity and overweight, in a group of Spanish subjects Int J Obes Relat Metab Disord 28 697 705 14993911
263. J Daly AP Sindone DR Thompson K Hancock E Chang P Davidson 2002 Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review Prog Cardiovasc Nurs 17 8 17 11872976
264. MA Jacobs-van der Bruggen G Bos WJ Bemelmans RT Hoogenveen SM Vijgen CA Baan 2007 Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study Diabetes Care 30 128 134 17192345
265. Bemelmans WJ, Wendel-Vos GCW, Bogers RP, et al. (2008) [Cost effectiveness of exercise and healthy diet counseling among people with increased risk of type II diabetes mellitus. Literature research and model simulations concerning 'de Beweegkuur']. RIVM report 260401005, RIVM Bilthoven, The Netherlands, 123 pages, downloaded on March 26th, 2009 from http://www.rivm.nl/bibliotheek/rapporten/260401005.html
266. L Roux M Pratt TO Tengs, et al.. 2008 Cost effectiveness of community-based physical activity interventions Am J Prev Med 35 578 588 19000846
267. N Gusi MC Reyes JL Gonzalez-Guerrero E Herrera JM Garcia 2008 Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: a randomised controlled trial BMC Public Health 8 231 18611277
268. J Wylie-Rosett WH Herman RB Goldberg 2006 Lifestyle intervention to prevent diabetes: intensive and cost effective Curr Opin Lipidol 17 37 44 16407714
269. SM Vijgen M Hoogendoorn CA Baan GA de Wit W Limburg TL Feenstra 2006 Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review Pharmacoeconomics 24 425 441 16706569
270. WH Herman TJ Hoerger M Brandle, et al.. 2005 The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance Ann Intern Med 142 323 332 15738451
271. DH Ryan MA Espeland GD Foster, et al.. 2003 Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes Control Clin Trials 24 610 628 14500058
272. J Fredriksson D Anevski P Almgren, et al.. 2007 Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality PLoS ONE 2 e285 17356695
273. MH De Moor D Posthuma JJ Hottenga G Willemsen DI Boomsma EJ De Geus 2007 Genome-wide linkage scan for exercise participation in Dutch sibling pairs Eur J Hum Genet 15 1252 1259 17700629